Europe Infectious Disease Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Kits & Reagents, Instruments, and Software & Services), Technology (Immunodiagnostics, Polymerase Chain Reaction, Next Generation Sequencing, Clinical Microbiology, and Others), Testing Type (Laboratory Testing and Point of Care Testing), Disease Indication (HIV, Hepatitis, Healthcare-Associated Infections, Human Papillomavirus, Tuberculosis, Influenza, and Others), and End User (Hospitals and Clinics, Pathology/Diagnostic Laboratories, Research Institutes, Home Care Settings, and Others)
The Europe infectious disease diagnostics market is expected to grow from US$ 7,164.17 million in 2021 to US$ 11,159.47 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028.
Research and development (R&D) are tremendously significant in the business of pharmaceuticals & biopharmaceutical companies. R&D enables these companies to develop new products for various therapeutic applications with significant medical and commercial potential. Further, leading market players are investing in R&D to develop advanced technologies and gain more revenue share. Moreover, testing is one of the best tools to understand and manage COVID-19. In response to the rising cases of COVID-19 and limited laboratory capabilities and molecular testing reagents, a few diagnostic testing manufacturers are offering fast and easy-to-use devices to facilitate out-of-laboratory testing. The simple test kits are based on detecting proteins of COVID-19 from respiratory samples (sputum and swabs of the throat) or human antibodies produced due to infection in blood or serum. Rising focus on R&D and funding in infectious disease diagnostics are driving the infectious disease diagnostics market growth across the region.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe infectious disease diagnostics market at a notable CAGR during the forecast period.
Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
Europe Infectious Disease Diagnostics Market Segmentation
The Europe infectious disease diagnostics market is analyzed based on product, technology, testing type, disease indication and end user, and country. Based on product, the Europe infectious disease diagnostics market, has been segmented into kits and reagents, instruments, and software and services. The kits and reagents segment dominated the market in 2020 and software and services segment is expected to be fastest growing during forecast period. Based on technology, the market is segmented into immunodiagnostics, polymerase chain reaction, next generation sequencing, clinical microbiology, and others. The next generation sequencing segment dominated the market in 2020 and is expected to be fastest growing during forecast period. Based on testing type, the market is segmented into laboratory testing and point of care testing. The laboratory testing segment dominated the market in 2020 and point of care testing segment is expected to be fastest growing during forecast period. Based on disease indication, the market is segmented into HIV, Hepatitis, Healthcare Associated Infections, Human Papillomavirus, Tuberculosis, Influenza, and Others. The hepatitis segment dominated the market in 2020 and healthcare- associated infections (HAIs) segment is expected to be fastest growing during forecast period. Based on end user, the Europe infectious disease diagnostics market, has been segmented into hospitals and clinics, pathology/ diagnostic laboratories, research institutes, home care settings, and others. The pathology/ diagnostic laboratories segment dominated the market in 2020 and home care settings segment is expected to be fastest growing during forecast period. Based on country, the Europe infectious disease diagnostics market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe.
Abbott; AccuBioTech Co., Ltd.; ACON Laboratories, Inc.; BD; bioMerieux SA; BIO-RAD LABORATORIES INC.; Cardinal Health Inc; Danaher; F. HOFFMANN-LA ROCHE LTD.; and Trinity Biotechare are among the leading companies operating in the Europe infectious disease diagnostics market.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Infectious Disease Diagnostics Market – By Product
1.3.2 Europe Infectious Disease Diagnostics Market – By Technology
1.3.3 Europe Infectious Disease Diagnostics Market – By Testing Type
1.3.4 Europe Infectious Disease Diagnostics Market – By Disease Indication
1.3.5 Europe Infectious Disease Diagnostics Market – By End User
1.3.6 Europe Infectious Disease Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Infectious Disease Diagnostics Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Infectious Disease Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Prevalence of Infectious Diseases
5.1.2 Growing Focus on R&D and Funding in Infectious Disease Diagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Growing Opportunities in Developing Nations
5.4 Future Trend
5.4.1 Upsurge in the Number of Product Approvals and Launches
5.5 Impact Analysis
6. Infectious Disease Diagnostics Market– Europe Analysis
6.1 Europe Infectious Disease Diagnostics Market Revenue Forecast and Analysis
7. Europe Infectious Disease Diagnostics Market Revenue and Forecast To 2028– by Product
7.1 Overview
7.2 Europe by Product: Market Revenue and Forecast Analysis (US$ Million)
7.3 Kits and Reagents
7.3.1 Overview
7.3.2 Kits and Reagents Market Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market Revenue and Forecast to 2028 (US$ Million)
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services Market Revenue and Forecast to 2028 (US$ Million)
8. Europe Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Technology
8.1 Europe Infectious Disease Diagnostics Market Revenue Share, by Technology (2021 and 2028)
8.2 Immunodiagnostics
8.2.1 Overview
8.2.2 Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Polymerase Chain Reaction (PCR)
8.3.1 Overview
8.3.2 PCR: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Next Generation Sequencing
8.4.1 Overview
8.4.2 Next Generation Sequencing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Clinical Microbiology
8.5.1 Overview
8.5.2 Clinical Microbiology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Testing Type
9.1 Europe Infectious Disease Diagnostics Market Revenue Share, by Testing Type (2021 and 2028)
9.2 Laboratory Testing
9.2.1 Overview
9.2.2 Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Point of Care Testing
9.3.1 Overview
9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Disease Indication
10.1 Overview
10.2 Europe Infectious Disease Diagnostics Market Revenue Share, by Disease Indication (2021 and 2028)
10.3 HIV
10.3.1 Overview
10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)
10.4 Hepatitis
10.4.1 Overview
10.4.2 Hepatitis Market Revenue and Forecast to 2028 (US$ Million)
10.5 Healthcare Associated Infections (HAIs)
10.5.1 Overview
10.5.2 Hospital Associated Infections (HAIs) Market Revenue and Forecast to 2028 (US$ Million)
10.6 Human Papillomavirus (HPV)
10.6.1 Overview
10.6.2 Human Papillomavirus (HPV) Market Revenue and Forecast to 2028 (US$ Million)
10.7 Tuberculosis (TB)
10.7.1 Overview
10.7.2 Tuberculosis (TB) Market Revenue and Forecast to 2028 (US$ Million)
10.8 Influenza
10.8.1 Overview
10.8.2 Influenza Market Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)
11. Europe Infectious Disease Diagnostics Market Analysis – by End User
11.1 Overview
11.2 Europe Infectious Disease Diagnostics Market Revenue Share, by End User (2021 and 2028)
11.3 Hospitals and Clinics
11.3.1 Overview
11.3.2 Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Pathology or Diagnostic Laboratories
11.4.1 Overview
11.4.2 Pathology or Diagnostics Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11.5 Research Institutes
11.5.1 Overview
11.5.2 Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11.6 Home Care Settings
11.6.1 Overview
11.6.2 Home Care Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11.7 Others
11.7.1 Overview
11.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12. Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2028 – Country Analysis
12.1 Europe: Infectious Disease Diagnostics Market
12.1.1 Overview
12.1.2 Europe: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)
12.1.2.1 Germany: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.1 Germany: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.2 Germany: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.3 Germany: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.4 Germany: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.5 Germany: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.6 Germany: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
12.1.2.2 France: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.1 France: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.2 France: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.3 France: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.4 France: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.5 France: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.6 France: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
12.1.2.3 UK: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.1 UK: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.2 UK: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.3 UK: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.4 UK: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.5 UK: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.6 UK: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
12.1.2.4 Italy: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.1 Italy: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.2 Italy: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.3 Italy: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.4 Italy: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.5 Italy: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.6 Italy: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
12.1.2.5 Spain: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.1 Spain: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.2 Spain: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.3 Spain: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.4 Spain: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.5 Spain: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.6 Spain: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
12.1.2.6 Rest of Europe: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.1 Rest of Europe: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.2 Rest of Europe: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.3 Rest of Europe: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.4 Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.5 Rest of Europe: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.6 Rest of Europe: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
13. Industry Landscape
13.1 Overview
13.2 Organic Developments
13.2.1 Overview
13.3 Inorganic Developments
13.3.1 Overview
14. Company Profiles
14.1 Danaher
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Abbott
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 BD
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Trinity Biotech
14.4.1 1.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 F. HOFFMANN-LA ROCHE LTD.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Cardinal Health Inc.
14.6.1 1.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 bioMerieux SA
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 BIO-RAD LABORATORIES INC.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 AccuBioTech Co., Ltd.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 ACON Laboratories, Inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
LIST OF TABLES
Table 1. Europe Infectious Disease Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
Table 2. Germany: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. France: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 11. France: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 12. UK: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 13. UK: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 14. UK: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. UK: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 19. Italy: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 21. Italy: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 22. Spain: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 23. Spain: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 24. Spain: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 25. Spain: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 26. Spain: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 27. Rest of Europe: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 28. Rest of Europe: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 29. Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)
Table 30. Rest of Europe: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 32. Organic Developments Done By Companies
Table 33. Inorganic Developments Done By Companies
Table 34. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Infectious Disease Diagnostics Market Segmentation
Figure 2. Europe Infectious Disease Diagnostics Market, By Country
Figure 3. Europe Infectious Disease Diagnostics Market Overview
Figure 4. Europe Infectious Disease Diagnostics Market, by Product
Figure 5. Europe Infectious Disease Diagnostics Market, by Country
Figure 6. Europe: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Europe Infectious Disease Diagnostics Market Impact Analysis of Drivers and Restraints
Figure 9. Europe Infectious Disease Diagnostics Market– Revenue Forecast and Analysis
Figure 10. Europe by Product: Market Analysis and Forecast 2021 and 2028 (%)
Figure 11. Europe Kits and Reagents Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. Europe Instruments Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Software and Services Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Infectious Disease Diagnostics Market Revenue Share, by Technology (2021 and 2028)
Figure 15. Europe Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe PCR: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Next Generation Sequencing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Clinical Microbiology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Europe Infectious Disease Diagnostics Market Revenue Share, by Testing Type (2021 and 2028)
Figure 21. Europe Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe Infectious Disease Diagnostics Market Revenue Share, by Disease Indication (2021 and 2028)
Figure 24. Europe HIV Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Europe Hepatitis Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. Europe Hospital Associated Infections (HAIs) Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Europe Human Papillomavirus (HPV) Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. Europe Tuberculosis (TB) Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe Influenza Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. Europe Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. Europe Infectious Disease Diagnostics Market Revenue Share, by End User (2021 and 2028)
Figure 32. Europe Hospitals: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Europe Pathology or Diagnostics Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Europe Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Europe Home Care Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Europe Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Europe: Infectious Disease Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 38. Europe: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 39. Germany: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. France: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. UK: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Italy: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Spain: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Rest of Europe: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- Abbott
- AccuBioTech Co., Ltd.
- ACON Laboratories, Inc.
- BD
- bioMerieux SA
- BIO-RAD LABORATORIES INC.
- Cardinal Health Inc
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- Trinity Biotech
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe infectious disease diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe infectious disease diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the infectious disease diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution